{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:23:20Z","timestamp":1769124200014,"version":"3.49.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10741-021-10164-z","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:41:46Z","timestamp":1631580106000},"page":"1485-1492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The genetics of cardiac amyloidosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Scott","family":"Arno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0791-6594","authenticated-orcid":false,"given":"Jennifer","family":"Cowger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"15","key":"10164_CR1","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood-2009-06-223792","volume":"115","author":"AJ Stangou","year":"2010","unstructured":"Stangou AJ, Banner NR, Hendry BM et al (2010) Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood 115(15):2998\u20133007. https:\/\/doi.org\/10.1182\/blood-2009-06-223792","journal-title":"Blood"},{"issue":"4","key":"10164_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/13506120309041738","volume":"10","author":"D Coriu","year":"2003","unstructured":"Coriu D, Dispenzieri A, Stevens FJ et al (2003) Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 10(4):215\u2013223. https:\/\/doi.org\/10.3109\/13506120309041738","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"5","key":"10164_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s10157-011-0483-4","volume":"15","author":"R Morizane","year":"2011","unstructured":"Morizane R, Monkawa T, Konishi K et al (2011) Renal amyloidosis caused by apolipoprotein A-II without a genetic mutation in the coding sequence. Clin Exp Nephrol 15(5):774\u2013779. https:\/\/doi.org\/10.1007\/s10157-011-0483-4","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"10164_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13023-020-1300-5","volume":"15","author":"E-K Schmidt","year":"2020","unstructured":"Schmidt E-K, Mustonen T, Kiuru-Enari S, Kivel\u00e4 TT, Atula S (2020) Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study. Orphanet J Rare Dis 15(1):19. https:\/\/doi.org\/10.1186\/s13023-020-1300-5","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10164_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1053\/j.ajkd.2018.10.016","volume":"74","author":"JM Mejia-Vilet","year":"2019","unstructured":"Mejia-Vilet JM, C\u00e1rdenas-Mastrascusa LR, Palacios-Cebreros EJ et al (2019) LECT2 amyloidosis in kidney transplantation: a report of 5 Cases. Am J Kidney Dis Off J Natl Kidney Found 74(4):563\u2013566. https:\/\/doi.org\/10.1053\/j.ajkd.2018.10.016","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"10164_CR6","doi-asserted-by":"publisher","unstructured":"Wei LH, Walker LC, Levy E, Cystatin C (1996) Icelandic-like mutation in an animal model of cerebrovascular beta-amyloidosis. Stroke\u00a027(11):2080\u20132085. https:\/\/doi.org\/10.1161\/01.str.27.11.2080","DOI":"10.1161\/01.str.27.11.2080"},{"issue":"16","key":"10164_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMc1917321","volume":"382","author":"S Ravichandran","year":"2020","unstructured":"Ravichandran S, Lachmann HJ, Wechalekar AD (2020) Epidemiologic and survival trends in amyloidosis, 1987\u20132019. N Engl J Med 382(16):1567\u20131568. https:\/\/doi.org\/10.1056\/NEJMc1917321","journal-title":"N Engl J Med"},{"issue":"6","key":"10164_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ckj\/sfv087","volume":"8","author":"MM Picken","year":"2015","unstructured":"Picken MM (2015) Proteomics and mass spectrometry in the diagnosis of renal amyloidosis. Clin Kidney J 8(6):665\u2013672. https:\/\/doi.org\/10.1093\/ckj\/sfv087","journal-title":"Clin Kidney J"},{"issue":"D1","key":"10164_CR9","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M et al (2018) ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 46(D1):D1062\u2013D1067. https:\/\/doi.org\/10.1093\/nar\/gkx1153","journal-title":"Nucleic Acids Res"},{"key":"10164_CR10","doi-asserted-by":"publisher","unstructured":"Koike H, Katsuno M (2019) Ultrastructure in transthyretin amyloidosis: from pathophysiology to therapeutic insights. Biomedicines\u00a07(1). https:\/\/doi.org\/10.3390\/biomedicines7010011","DOI":"10.3390\/biomedicines7010011"},{"issue":"1","key":"10164_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41467-019-08609-z","volume":"10","author":"AW Yee","year":"2019","unstructured":"Yee AW, Aldeghi M, Blakeley MP et al (2019) A molecular mechanism for transthyretin amyloidogenesis. Nat Commun 10(1):925. https:\/\/doi.org\/10.1038\/s41467-019-08609-z","journal-title":"Nat Commun"},{"issue":"10","key":"10164_CR12","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg FL, Berk JL (2012) Transthyretin (TTR) cardiac amyloidosis. Circulation 126(10):1286\u20131300. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.078915","journal-title":"Circulation"},{"issue":"2","key":"10164_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","volume":"68","author":"MS Maurer","year":"2016","unstructured":"Maurer MS, Hanna M, Grogan M et al (2016) Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (transthyretin amyloid outcome survey). J Am Coll Cardiol 68(2):161\u2013172. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.596","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10164_CR14","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/archneur.58.11.1914","volume":"58","author":"A Yoshioka","year":"2001","unstructured":"Yoshioka A, Yamaya Y, Saiki S et al (2001) A case of familial amyloid polyneuropathy homozygous for the transthyretin Val30Met gene with motor-dominant sensorimotor polyneuropathy and unusual sural nerve pathological findings. Arch Neurol 58(11):1914\u20131918. https:\/\/doi.org\/10.1001\/archneur.58.11.1914","journal-title":"Arch Neurol"},{"key":"10164_CR15","doi-asserted-by":"publisher","unstructured":"da Silva-Batista JA, Marques W, Oliveira MT de JS et al (2020) Presence of val30Met and val122ile mutations in a patient with hereditary amyloidosis. J Hum Genet 65(8):711\u2013713.\u00a0https:\/\/doi.org\/10.1038\/s10038-020-0749-3","DOI":"10.1038\/s10038-020-0749-3"},{"issue":"6","key":"10164_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002558","volume":"9","author":"KB Shah","year":"2016","unstructured":"Shah KB, Mankad AK, Castano A et al (2016) Transthyretin cardiac amyloidosis in black Americans. Circ Heart Fail 9(6):e002558. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002558","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10164_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/13506129.2015.1019610","volume":"22","author":"PL Swiecicki","year":"2015","unstructured":"Swiecicki PL, Zhen DB, Mauermann ML et al (2015) Hereditary ATTR amyloidosis: a single-institution experience with 266 patients. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 22(2):123\u2013131. https:\/\/doi.org\/10.3109\/13506129.2015.1019610","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"1","key":"10164_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1404852","volume":"372","author":"CC Quarta","year":"2015","unstructured":"Quarta CC, Buxbaum JN, Shah AM et al (2015) The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med 372(1):21\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1404852","journal-title":"N Engl J Med"},{"issue":"5","key":"10164_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ahj.2010.02.006","volume":"159","author":"J Buxbaum","year":"2010","unstructured":"Buxbaum J, Alexander A, Koziol J, Tagoe C, Fox E, Kitzman D (2010) Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Am Heart J 159(5):864\u2013870. https:\/\/doi.org\/10.1016\/j.ahj.2010.02.006","journal-title":"Am Heart J"},{"issue":"2","key":"10164_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s004390050199","volume":"98","author":"DR Jacobson","year":"1996","unstructured":"Jacobson DR, Pastore R, Pool S et al (1996) Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 98(2):236\u2013238. https:\/\/doi.org\/10.1007\/s004390050199","journal-title":"Hum Genet"},{"issue":"9","key":"10164_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jamacardio.2018.2093","volume":"3","author":"KM Alexander","year":"2018","unstructured":"Alexander KM, Orav J, Singh A et al (2018) Geographic disparities in reported US amyloidosis mortality from 1979 to 2015: potential underdetection of cardiac amyloidosis. JAMA Cardiol 3(9):865\u2013870. https:\/\/doi.org\/10.1001\/jamacardio.2018.2093","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10164_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","volume":"12","author":"MS Maurer","year":"2019","unstructured":"Maurer MS, Bokhari S, Damy T et al (2019) Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail 12(9):e006075. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006075","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10164_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jacc.2016.09.987","volume":"69","author":"A Singh","year":"2017","unstructured":"Singh A, Geller HI, Falk RH (2017) Val122Ile mt-ATTR has a worse survival than wt-ATTR cardiac amyloidosis. J Am Coll Cardiol 69(6):757\u2013758. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.987","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10164_CR24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2019.17935","volume":"322","author":"SM Damrauer","year":"2019","unstructured":"Damrauer SM, Chaudhary K, Cho JH et al (2019) Association of the V122I hereditary transthyretin amyloidosis genetic variant with heart failure among individuals of African or Hispanic\/Latino ancestry. JAMA 322(22):2191\u20132202. https:\/\/doi.org\/10.1001\/jama.2019.17935","journal-title":"JAMA"},{"issue":"3","key":"10164_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.amjcard.2011.03.069","volume":"108","author":"D Jacobson","year":"2011","unstructured":"Jacobson D, Tagoe C, Schwartzbard A, Shah A, Koziol J, Buxbaum J (2011) Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men. Am J Cardiol 108(3):440\u2013444. https:\/\/doi.org\/10.1016\/j.amjcard.2011.03.069","journal-title":"Am J Cardiol"},{"issue":"3","key":"10164_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ejhf.1742","volume":"22","author":"A Milandri","year":"2020","unstructured":"Milandri A, Farioli A, Gagliardi C et al (2020) Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies. Eur J Heart Fail 22(3):507\u2013515. https:\/\/doi.org\/10.1002\/ejhf.1742","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10164_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","volume":"74","author":"EL Fosb\u00f8l","year":"2019","unstructured":"Fosb\u00f8l EL, R\u00f8rth R, Leicht BP et al (2019) Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes. J Am Coll Cardiol 74(1):15\u201323. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.054","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10164_CR28","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","volume":"72","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Reyes BA, Ikram A et al (2018) Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. J Am Coll Cardiol 72(17):2040\u20132050. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.092","journal-title":"J Am Coll Cardiol"},{"key":"10164_CR29","doi-asserted-by":"publisher","unstructured":"Van Dyke M, Greer S, Odom E et al (2018) Heart disease death rates among blacks and whites aged \u226535 years - United States, 1968\u20132015. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002 67(5):1\u201311. https:\/\/doi.org\/10.15585\/mmwr.ss6705a1","DOI":"10.15585\/mmwr.ss6705a1"},{"issue":"9","key":"10164_CR30","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/eurheartj\/ehr383","volume":"33","author":"PT Sattianayagam","year":"2012","unstructured":"Sattianayagam PT, Hahn AF, Whelan CJ et al (2012) Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. Eur Heart J 33(9):1120\u20131127. https:\/\/doi.org\/10.1093\/eurheartj\/ehr383","journal-title":"Eur Heart J"},{"issue":"1","key":"10164_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp.59.1.45","volume":"59","author":"MM Reilly","year":"1995","unstructured":"Reilly MM, Staunton H, Harding AE (1995) Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study. J Neurol Neurosurg Psychiatry 59(1):45\u201349. https:\/\/doi.org\/10.1136\/jnnp.59.1.45","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10164_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/art.1780300210","volume":"30","author":"MD Benson","year":"1987","unstructured":"Benson MD, Wallace MR, Tejada E, Baumann H, Page B (1987) Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy. Appalachian amyloid Arthritis Rheum 30(2):195\u2013200. https:\/\/doi.org\/10.1002\/art.1780300210","journal-title":"Appalachian amyloid Arthritis Rheum"},{"issue":"9","key":"10164_CR33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/mus.880080902","volume":"8","author":"AH Koeppen","year":"1985","unstructured":"Koeppen AH, Mitzen EJ, Hans MB, Peng SK, Bailey RO (1985) Familial amyloid polyneuropathy. Muscle Nerve 8(9):733\u2013749. https:\/\/doi.org\/10.1002\/mus.880080902","journal-title":"Muscle Nerve"},{"issue":"2","key":"10164_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3121\/cmr.2008.794","volume":"6","author":"T Rudolph","year":"2008","unstructured":"Rudolph T, Kurz MW, Farbu E (2008) Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history. Clin Med Res 6(2):80\u201382. https:\/\/doi.org\/10.3121\/cmr.2008.794","journal-title":"Clin Med Res"},{"issue":"1","key":"10164_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/13506120209072442","volume":"9","author":"N Kotani","year":"2002","unstructured":"Kotani N, Hattori T, Yamagata S et al (2002) Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 9(1):31\u201334. https:\/\/doi.org\/10.3109\/13506120209072442","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"2","key":"10164_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s0387-7604(84)80061-3","volume":"6","author":"S Araki","year":"1984","unstructured":"Araki S (1984) Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 6(2):128\u2013133. https:\/\/doi.org\/10.1016\/s0387-7604(84)80061-3","journal-title":"Brain Dev"},{"issue":"24","key":"10164_CR37","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa CE, Connelly S, Devit M et al (2012) Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A 109(24):9629\u20139634. https:\/\/doi.org\/10.1073\/pnas.1121005109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10164_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13023-017-0726-x","volume":"13","author":"Y Sekijima","year":"2018","unstructured":"Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y (2018) Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis 13(1):6. https:\/\/doi.org\/10.1186\/s13023-017-0726-x","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10164_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/jmg.31.4.293","volume":"31","author":"T Coelho","year":"1994","unstructured":"Coelho T, Sousa A, Louren\u00e7o E, Ramalheira J (1994) A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 31(4):293\u2013299. https:\/\/doi.org\/10.1136\/jmg.31.4.293","journal-title":"J Med Genet"},{"issue":"3","key":"10164_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/13506120802193720","volume":"15","author":"U Hellman","year":"2008","unstructured":"Hellman U, Alarcon F, Lundgren H-E, Suhr OB, Bonaiti-Pelli\u00e9 C, Plant\u00e9-Bordeneuve V (2008) Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 15(3):181\u2013186. https:\/\/doi.org\/10.1080\/13506120802193720","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"6","key":"10164_CR41","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ajmg.1320600606","volume":"60","author":"A Sousa","year":"1995","unstructured":"Sousa A, Coelho T, Barros J, Sequeiros J (1995) Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in P\u00f3voa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 60(6):512\u2013521. https:\/\/doi.org\/10.1002\/ajmg.1320600606","journal-title":"Am J Med Genet"},{"issue":"21","key":"10164_CR42","doi-asserted-by":"publisher","first-page":"e1999","DOI":"10.1212\/WNL.0000000000006543","volume":"91","author":"T Coelho","year":"2018","unstructured":"Coelho T, In\u00eas M, Concei\u00e7\u00e3o I, Soares M, de Carvalho M, Costa J (2018) Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy. Neurology 91(21):e1999\u2013e2009. https:\/\/doi.org\/10.1212\/WNL.0000000000006543","journal-title":"Neurology"},{"issue":"3","key":"10164_CR43","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/13506120600876849","volume":"13","author":"OB Suhr","year":"2006","unstructured":"Suhr OB, Lindqvist P, Olofsson B-O, Waldenstr\u00f6m A, Backman C (2006) Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 13(3):154\u2013159. https:\/\/doi.org\/10.1080\/13506120600876849","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"Suppl 1","key":"10164_CR44","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","volume":"29","author":"Y Parman","year":"2016","unstructured":"Parman Y, Adams D, Obici L et al (2016) Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol 29(Suppl 1):S3\u2013S13. https:\/\/doi.org\/10.1097\/WCO.0000000000000288","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10164_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/jnnp-2013-305383","volume":"85","author":"C Lemos","year":"2014","unstructured":"Lemos C, Coelho T, Alves-Ferreira M et al (2014) Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M. J Neurol Neurosurg Psychiatry 85(3):326\u2013330. https:\/\/doi.org\/10.1136\/jnnp-2013-305383","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10164_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1212\/wnl.55.3.451-a","volume":"55","author":"K Misu","year":"2000","unstructured":"Misu K, Hattori N, Ando Y, Ikeda S, Sobue G (2000) Anticipation in early- but not late-onset familial amyloid polyneuropathy (TTR met 30) in Japan. Neurology 55(3):451\u2013452. https:\/\/doi.org\/10.1212\/wnl.55.3.451-a","journal-title":"Neurology"},{"issue":"4","key":"10164_CR47","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/13506129.2020.1789580","volume":"27","author":"E Cisneros-Barroso","year":"2020","unstructured":"Cisneros-Barroso E, Gonz\u00e1lez-Moreno J, Rodr\u00edguez A et al (2020) Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 27(4):254\u2013258. https:\/\/doi.org\/10.1080\/13506129.2020.1789580","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"6","key":"10164_CR48","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s004390050991","volume":"104","author":"M Soares","year":"1999","unstructured":"Soares M, Buxbaum J, Sirugo G et al (1999) Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions. Hum Genet 104(6):480\u2013485. https:\/\/doi.org\/10.1007\/s004390050991","journal-title":"Hum Genet"},{"issue":"1","key":"10164_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jmg.35.1.23","volume":"35","author":"K Yamamoto","year":"1998","unstructured":"Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N (1998) A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet 35(1):23\u201330. https:\/\/doi.org\/10.1136\/jmg.35.1.23","journal-title":"J Med Genet"},{"issue":"2","key":"10164_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1399-0004.2008.01097.x","volume":"75","author":"M Olsson","year":"2009","unstructured":"Olsson M, Hellman U, Plant\u00e9-Bordeneuve V, Jonasson J, L\u00e5ng K, Suhr OB (2009) Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients. Clin Genet 75(2):163\u2013168. https:\/\/doi.org\/10.1111\/j.1399-0004.2008.01097.x","journal-title":"Clin Genet"},{"issue":"Suppl 1","key":"10164_CR51","doi-asserted-by":"publisher","first-page":"O4","DOI":"10.1186\/1750-1172-10-S1-O4","volume":"10","author":"D Santos","year":"2015","unstructured":"Santos D, Coelho T, Alves-Ferreira M et al (2015) The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M. Orphanet J Rare Dis 10(Suppl 1):O4. https:\/\/doi.org\/10.1186\/1750-1172-10-S1-O4","journal-title":"Orphanet J Rare Dis"},{"issue":"22","key":"10164_CR52","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1161\/CIRCULATIONAHA.111.040071","volume":"124","author":"M Movassagh","year":"2011","unstructured":"Movassagh M, Choy M-K, Knowles DA et al (2011) Distinct epigenomic features in end-stage failing human hearts. Circulation 124(22):2411\u20132422. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.040071","journal-title":"Circulation"},{"issue":"3","key":"10164_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/HCO.0000000000000276","volume":"31","author":"SY Kim","year":"2016","unstructured":"Kim SY, Morales CR, Gillette TG, Hill JA (2016) Epigenetic regulation in heart failure. Curr Opin Cardiol 31(3):255\u2013265. https:\/\/doi.org\/10.1097\/HCO.0000000000000276","journal-title":"Curr Opin Cardiol"},{"issue":"5","key":"10164_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2796.2004.01399.x","volume":"256","author":"G Holmgren","year":"2004","unstructured":"Holmgren G, Wikstr\u00f6m L, Lundgren H-E, Suhr OB (2004) Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins. J Intern Med 256(5):453\u2013456. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01399.x","journal-title":"J Intern Med"},{"key":"10164_CR55","doi-asserted-by":"publisher","unstructured":"Saporta MA da C, Plante-Bordeneuve V, Misrahi M, Cruz MW (2009) Discordant expression of familial amyloid polyneuropathy in monozygotic Brazilian twins. Amyloid Int J Exp Clin Investig Off J Int SocAmyloidosis 16(1):38\u201341. https:\/\/doi.org\/10.1080\/13506120802676955","DOI":"10.1080\/13506120802676955"},{"issue":"1","key":"10164_CR56","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13148-020-00967-6","volume":"12","author":"A De Lillo","year":"2020","unstructured":"De Lillo A, Pathak GA, De Angelis F et al (2020) Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis. Clin Epigenetics 12(1):176. https:\/\/doi.org\/10.1186\/s13148-020-00967-6","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10164_CR57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.003011","volume":"14","author":"GA Pathak","year":"2021","unstructured":"Pathak GA, Wendt FR, De Lillo A et al (2021) Epigenomic profiles of African-American Transthyretin Val122Ile carriers reveals putatively dysregulated amyloid mechanisms. Circ Genomic Precis Med 14(1):e003011. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003011","journal-title":"Circ Genomic Precis Med"},{"issue":"3","key":"10164_CR58","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41374-018-0104-x","volume":"99","author":"ME Pepin","year":"2019","unstructured":"Pepin ME, Ha C-M, Crossman DK et al (2019) Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure. Lab Investig J Tech Methods Pathol 99(3):371\u2013386. https:\/\/doi.org\/10.1038\/s41374-018-0104-x","journal-title":"Lab Investig J Tech Methods Pathol"},{"issue":"1","key":"10164_CR59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41467-017-02762-z","volume":"9","author":"R Gilsbach","year":"2018","unstructured":"Gilsbach R, Schwaderer M, Preissl S et al (2018) Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo. Nat Commun 9(1):391. https:\/\/doi.org\/10.1038\/s41467-017-02762-z","journal-title":"Nat Commun"},{"key":"10164_CR60","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/CLEP.S253612","volume":"12","author":"MP Lee","year":"2020","unstructured":"Lee MP, Glynn RJ, Schneeweiss S et al (2020) Risk factors for heart failure with preserved or reduced ejection fraction among medicare beneficiaries: application of competing risks analysis and gradient boosted model. Clin Epidemiol 12:607\u2013616. https:\/\/doi.org\/10.2147\/CLEP.S253612","journal-title":"Clin Epidemiol"},{"issue":"10","key":"10164_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222886","volume":"14","author":"C Andersson","year":"2019","unstructured":"Andersson C, Lyass A, Xanthakis V et al (2019) Risk factor-based subphenotyping of heart failure in the community. PLoS ONE 14(10):e0222886. https:\/\/doi.org\/10.1371\/journal.pone.0222886","journal-title":"PLoS ONE"},{"key":"10164_CR62","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1038\/ncomms9570","volume":"6","author":"MJ Peters","year":"2015","unstructured":"Peters MJ, Joehanes R, Pilling LC et al (2015) The transcriptional landscape of age in human peripheral blood. Nat Commun 6:8570. https:\/\/doi.org\/10.1038\/ncomms9570","journal-title":"Nat Commun"},{"issue":"7766","key":"10164_CR63","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Heard E (2019) Advances in epigenetics link genetics to the environment and disease. Nature 571(7766):489\u2013499. https:\/\/doi.org\/10.1038\/s41586-019-1411-0","journal-title":"Nature"},{"issue":"7300","key":"10164_CR64","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","volume":"322","author":"M Kivipelto","year":"2001","unstructured":"Kivipelto M, Helkala EL, Laakso MP et al (2001) Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study. BMJ 322(7300):1447\u20131451. https:\/\/doi.org\/10.1136\/bmj.322.7300.1447","journal-title":"BMJ"},{"issue":"5054","key":"10164_CR65","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013185. https:\/\/doi.org\/10.1126\/science.1566067","journal-title":"Science"},{"issue":"2","key":"10164_CR66","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3233\/JAD-2010-1240","volume":"19","author":"JK Cataldo","year":"2010","unstructured":"Cataldo JK, Prochaska JJ, Glantz SA (2010) Cigarette smoking is a risk factor for Alzheimer\u2019s disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis JAD 19(2):465\u2013480. https:\/\/doi.org\/10.3233\/JAD-2010-1240","journal-title":"J Alzheimers Dis JAD"},{"issue":"12","key":"10164_CR67","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/jmg.2005.033720","volume":"42","author":"G Holmgren","year":"2005","unstructured":"Holmgren G, Hellman U, Lundgren H-E, Sandgren O, Suhr OB (2005) Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome. J Med Genet 42(12):953\u2013956. https:\/\/doi.org\/10.1136\/jmg.2005.033720","journal-title":"J Med Genet"},{"issue":"1","key":"10164_CR68","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jmoldx.2013.08.001","volume":"16","author":"HV Reddi","year":"2014","unstructured":"Reddi HV, Jenkins S, Theis J et al (2014) Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life. J Mol Diagn JMD 16(1):68\u201374. https:\/\/doi.org\/10.1016\/j.jmoldx.2013.08.001","journal-title":"J Mol Diagn JMD"},{"issue":"28","key":"10164_CR69","doi-asserted-by":"publisher","first-page":"E6428","DOI":"10.1073\/pnas.1802977115","volume":"115","author":"ES Klimtchuk","year":"2018","unstructured":"Klimtchuk ES, Prokaeva T, Frame NM et al (2018) Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease. Proc Natl Acad Sci 115(28):E6428\u2013E6436. https:\/\/doi.org\/10.1073\/pnas.1802977115","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"10164_CR70","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41576-018-0057-3","volume":"19","author":"AM Elliott","year":"2018","unstructured":"Elliott AM, Friedman JM (2018) The importance of genetic counselling in genome-wide sequencing. Nat Rev Genet 19(12):735\u2013736. https:\/\/doi.org\/10.1038\/s41576-018-0057-3","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10164_CR71","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2217\/pme-2017-0001","volume":"14","author":"A Middleton","year":"2017","unstructured":"Middleton A, Mendes \u00c1, Benjamin CM, Howard HC (2017) Direct-to-consumer genetic testing: where and how does genetic counseling fit? Pers Med 14(3):249\u2013257. https:\/\/doi.org\/10.2217\/pme-2017-0001","journal-title":"Pers Med"},{"issue":"12","key":"10164_CR72","first-page":"906","volume":"36","author":"LN Lodder","year":"1999","unstructured":"Lodder LN, Frets PG, Trijsburg RW et al (1999) Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam\/Leiden Genetics Working Group. J Med Genet 36(12):906\u2013913","journal-title":"J Med Genet"},{"key":"10164_CR73","doi-asserted-by":"publisher","unstructured":"Oliveri S, Ferrari F, Manfrinati A, Pravettoni G (2018) A systematic review of the psychological implications of genetic testing: a comparative analysis among cardiovascular, Neurodegenerative and Cancer Diseases. Front Genet 9. https:\/\/doi.org\/10.3389\/fgene.2018.00624","DOI":"10.3389\/fgene.2018.00624"},{"key":"10164_CR74","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atg.2016.01.004","volume":"8","author":"L Hercher","year":"2016","unstructured":"Hercher L, Jamal L (2016) An old problem in a new age: revisiting the clinical dilemma of misattributed paternity. Appl Transl Genomics 8:36\u201339. https:\/\/doi.org\/10.1016\/j.atg.2016.01.004","journal-title":"Appl Transl Genomics"},{"key":"10164_CR75","doi-asserted-by":"publisher","unstructured":"Kapoor M, Rossor AM, Laura M, Reilly MM (2019) clinical presentation, diagnosis and treatment of TTR amyloidosis. J Neuromuscul Dis\u00a06(2):189\u2013199. https:\/\/doi.org\/10.3233\/JND-180371","DOI":"10.3233\/JND-180371"},{"key":"10164_CR76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/TCRM.S219979","volume":"16","author":"M Luigetti","year":"2020","unstructured":"Luigetti M, Romano A, Di Paolantonio A, Bisogni G, Sabatelli M (2020) Diagnosis and treatment of hereditary transthyretin amyloidosis (hATTR) polyneuropathy: current perspectives on improving patient care. Ther Clin Risk Manag 16:109\u2013123. https:\/\/doi.org\/10.2147\/TCRM.S219979","journal-title":"Ther Clin Risk Manag"},{"key":"10164_CR77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejim.2020.09.025","volume":"82","author":"A Porcari","year":"2020","unstructured":"Porcari A, Merlo M, Rapezzi C, Sinagra G (2020) Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery. Eur J Intern Med 82:7\u201315. https:\/\/doi.org\/10.1016\/j.ejim.2020.09.025","journal-title":"Eur J Intern Med"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10164-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10164-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10164-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T07:27:09Z","timestamp":1660807629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10164-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10164"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10164-z","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"17 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors here transfer all copyright ownership of the manuscript to Heart Failure Reviews in the event the work is published. The authors warrant that the article is original, does not infringe upon any copyright or other proprietary right of any third party, is not under consideration by another journal, and has not been previously published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Cowger is a consultant for Abbott (Abbott Parkway, IL), Medtronic (Minneapolis, MN), and Procyrion (Houston, Texas). There is no payment related to this paper herein; Arno has no disclosures.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Additional declarations for articles in life science journals that report the results of studies involving humans and\/or animals"}}]}}